New combo pill aims to extend life in tough bile duct cancer
Disease control
Recruiting now
This study tests whether adding an experimental drug (D07001) to standard chemotherapy (capecitabine) helps people with advanced bile duct cancer live longer. About 195 adults whose cancer has not responded to earlier treatments will receive either D07001 or a placebo, plus capec…
Phase: PHASE3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC